Markets WB starts Minerva Neurosciences at OP; fair value estimate $26 William Blair launched coverage of Minerva Neurosciences (NASDAQ:NERV) with an “outperform” rating and fair value estimate of $26. The stock closed at $8.11 on Sept. 17. Minerva is developing therapies for mood... September 18, 2019